ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2763

What Disease Do You Have? – Assessment and Predictors of Accurate Illness Naming in Rheumatology

Jacob Meindertsma1, Kara Harrison 1, Nicholas Lucchesi 1 and Adam Carlson 1, 1University of Virginia, Charlottesville, VA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnosis, doctor-patient relationship, Health literacy, patient, patient questionnaires and education

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T091: Patient Outcomes, Preferences, & Attitudes II: Patient Preferences, Beliefs, & Experiences (2762–2767)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Shared decision making remains central to the effective treatment of many rheumatologic conditions and is most appropriate when the patient and physician agree on which disease is being treated. Several studies in the oncology literature have shown that patients frequently do not understand their cancer diagnosis, including what stage of cancer or whether their cancer is in remission. Few studies to date have investigated whether patients with rheumatic disease have an accurate understanding of the diagnoses for which they are receiving treatment. In this study, we sought to assess the concordance between physician and patient reported diagnoses and factors associated with this concordance.

Methods: Over a four-week period in 2019, established patients presenting for a follow up visit in the University of Virginia Rheumatology Clinic were asked to complete a brief questionnaire. This questionnaire included self-reported diagnoses, an assessment of current disease activity, and demographic information. Patient reported diagnoses were compared with the diagnoses recorded by their rheumatologist in the electronic medical record. Allowing for misspellings and multiple answers, patients were considered concordant as long as one diagnosis was correctly identified. Eight patient characteristics including demographic and disease-specific variables were then compared between the concordant and discordant groups using chi-squared testing or Fisher’s exact test as appropriate.

Results: A total of 170 patients completed the questionnaire. Forty-two of 170 patients wrote responses that did not match their rheumatologist’s documented diagnosis (75.3% concordant, 24.7% discordant). Statistically significant predictors of discordance were non-white race (p = 0.02), non-English first language (p = 0.008), an annual household income below $50,000 (p = 0.007), and fewer years of completed education (p < 0.001). Predictors that did not associate with concordance were age, sex, disease length, and the type of disease (e.g. connective tissue disease, arthritis, vasculitis, etc.). Binary logistic regression modeling indicated that postgraduate education was the best predictor of concordance with an adjusted odds ratio of 3.4 (p = 0.002). Interestingly, patients who incorrectly named their diagnosis had a significantly higher score on a self-reported 100mm visual analog scale of global disease activity with an average of 34mm in the concordant group vs. 56mm in the discordant group (p < 0.001).

Conclusion: One quarter of surveyed patients inaccurately named their documented rheumatologic diagnosis. Poor agreement between patient and physician reported diagnoses spanned all types of rheumatic disease and was best predicted by lower levels of education. Poor agreement on diagnoses was also associated with higher patient reported global disease activity. This study reinforces the importance of addressing poor disease understanding in order to improve shared decision making between patients and their rheumatologists.


Disclosure: J. Meindertsma, None; K. Harrison, None; N. Lucchesi, None; A. Carlson, None.

To cite this abstract in AMA style:

Meindertsma J, Harrison K, Lucchesi N, Carlson A. What Disease Do You Have? – Assessment and Predictors of Accurate Illness Naming in Rheumatology [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/what-disease-do-you-have-assessment-and-predictors-of-accurate-illness-naming-in-rheumatology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-disease-do-you-have-assessment-and-predictors-of-accurate-illness-naming-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology